Nerviano Medical Sciences
Clinical trials sponsored by Nerviano Medical Sciences, explained in plain language.
-
New hope for recurrent ovarian cancer: targeted drug combo enters human testing
Disease control Recruiting nowThis early-stage study tests a new experimental drug (NMS-03305293) combined with a standard chemotherapy (topotecan) in 24 women whose ovarian cancer has returned after previous treatments. The main goals are to check safety and find the best dose, while also seeing if the combi…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
New hope for tough lung cancer? early trial tests targeted drug combo
Disease control Recruiting nowThis early-phase study tests a new targeted drug (NMS-03305293) combined with chemotherapy (Temozolomide) in about 10 people whose small cell lung cancer has returned after prior treatments. The main goal is to check safety and side effects, while also seeing if the combination c…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
New hope for tough leukemia: experimental drug targets resistant cancers
Disease control Recruiting nowThis early-phase study tests an experimental drug called NMS-03597812 in adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The study includes people with a specific genetic change (TP53 mutation) that often makes the cancer harde…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 20, 2026 11:54 UTC